PDS Planning, Inc

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 838618 DUBLIN, OH

Position in TEVA

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$274,970

+$47,474 QoQ

Shares Held

8,116

+7.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#172

of 308 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PDS Planning, Inc holds $1,750,619 across 5 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (15.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	62,103	$899,872
2	TEVA	Teva Pharmaceutical Industries Ltd This page	8,116	$274,970
3	TAK	Takeda Pharmaceutical Co Ltd	17,116	$274,369
4	HLN	Haleon plc	26,196	$244,408
5	AKBA	Akebia Therapeutics, Inc.	50,000	$57,000

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,970	8,116	+7.5%	Shares	Sole	2026-08-05
2026-03-31	$227,496	7,553	0.0%	Shares	Sole	2026-04-22
2025-12-31	$235,729	7,553	—	Shares	Sole	2026-01-26
No filing history on record for this holder in this stock.